$1.50 Special Dividend and $5M Buyback Announced After $100M Asset Sale
CPIX has more than doubled off its 52-week low of $1.85 on light trading volume (0.2× avg).
Summary
Cumberland Pharmaceuticals declared a $1.50 per share special dividend and authorized a $5 million share repurchase program. The moves follow the July 1 closing of its $100 million commercial product portfolio sale to Apotex, which transformed the company into a development-focused entity. The dividend alone represents about 24% of the current $6.125 stock price, signaling a substantial return of capital to shareholders. The buyback adds further support. With the asset sale proceeds now in hand, management is executing on its stated plan to reward investors while pivoting to its ifetroban pipeline.
At the time of this announcement, CPIX was trading at $6.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $91.8M. The 52-week trading range was $1.85 to $7.36. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.